المؤلفون: Richter Razafindratsimandresy, Marie‐Line Joffret, Jonhson Raharinantoanina, Patsy Polston, Nelson S. Andriamamonjy, Iony Manitra Razanajatovo, Ousmane M. Diop, Francis Delpeyroux, Jean‐Michel Héraud, Maël Bessaud

المساهمون: Institut Pasteur de Madagascar, Réseau International des Instituts Pasteur (RIIP), Signalisation antivirale - Virus sensing and signaling, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Institut Pasteur [Paris] (IP), World Health Organisation (WHO), Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), Dennis and Mireille Gillings FoundationUS CDCWorld Health Organization

المصدر: Journal of Medical Virology
Journal of Medical Virology, 2022, 94 (12), pp.5877-5884. ⟨10.1002/jmv.28071⟩

مصطلحات موضوعية: Poliovirus, Infectious Diseases, [SDV]Life Sciences [q-bio], Poliovirus Vaccine, Oral, Virology, [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology, Madagascar, Humans, [SDV.IMM.VAC]Life Sciences [q-bio]/Immunology/Vaccinology, Child, Serogroup, Enterovirus, Poliomyelitis

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a83ffa584792a4dc76077dff23ce4ab2
https://doi.org/10.1002/jmv.28071

المؤلفون: Yvonne C F Su, Jordan Z J Ma, Tey Putita Ou, Leakhena Pum, Sidonn Krang, Philomena Raftery, Michael H Kinzer, Jennifer Bohl, Vanra Ieng, Vannda Kab, Sarika Patel, Borann Sar, Wong Foong Ying, Jayanthi Jayakumar, Viseth Srey Horm, Narjis Boukli, Sokhoun Yann, Cecile Troupin, Vireak Heang, Jose A Garcia-Rivera, Yi Sengdoeurn, Seng Heng, Sreyngim Lay, Sophana Chea, Chau Darapheak, Chin Savuth, Asheena Khalakdina, Sowath Ly, Laurence Baril, Jessica E Manning, Etienne Simone-Loriere, Veasna Duong, Philippe Dussart, Ly Sovann, Gavin J D Smith, Erik A Karlsson

المساهمون: Duke-NUS Medical School [Singapore], Institut Pasteur du Cambodge, Réseau International des Instituts Pasteur (RIIP), Université de Montpellier (UM), Ministry of Health [Phnom Penh], World Health Organization [Phnom Penh] (WHO), Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), Centers for Disease Control and Prevention [Phnom Penh], Embassy of the United States of America, National Institute of Allergy and Infectious Diseases [Phnom Penh, Cambodia] (NIAID), National Institute of Allergy and Infectious Diseases [Bethesda] (NIAID-NIH), National Institutes of Health [Bethesda] (NIH)-National Institutes of Health [Bethesda] (NIH), US Naval Medical Research Unit n°2, National Institute of Public Health [Phnom Penh, Cambodge], Département de Virologie - Department of Virology, Institut Pasteur [Paris] (IP), Duke University [Durham], The work at Institut Pasteur du Cambodge is supported by the WHO, the European Union, The Pasteur International Center for Research on Emerging Infectious Diseases National Institutes of Health, Department of Health and Human Services funded project No. 1U01AI151758-01, Wellcome Trust grant 222574/Z/21/Z, the British Embassy in Cambodia, and French Development Agency-funded ECOnomic development, ECOsystem MOdifications, and emerging infectious diseases Risk Evaluation (ECOMORE) 2 COVID-19 top up project No. CZZ 2146 01A. E.A.K. was funded, in part, by federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services Contract No. 75N93021C00015. The study was supported by the Duke-NUS Signature Research Programme funded by the Ministry of Health, Singapore, and by contracts HHSN272201400006C and 75N93021C00016 from the National Institute of Allergy and Infectious Disease, National Institutes of Health, Department of Health and Human Services, USA. This work was funded in part by the Division of Intramural Research at National Institute of Allergy and Infectious Diseases at the National Institutes of Health and Bill and Melinda Gates Foundation Grant OPP1211806. E.S.L. acknowledges funding from the INCEPTION programme (Investissements d’Avenir), grant number ANR-16-CONV-0005., ANR-16-CONV-0005,INCEPTION,Institut Convergences pour l'étude de l'Emergence des Pathologies au Travers des Individus et des populatiONs(2016)

المصدر: Virus Evolution
Virus Evolution, 2023, 9 (1), pp.veac121. ⟨10.1093/ve/veac121⟩

مصطلحات موضوعية: pandemic, [SDV]Life Sciences [q-bio], Virology, coronavirus, COVID-19, genetic diversity, phylogeny, Microbiology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae0eea8706803ba7e59e2775215778a2
https://doi.org/10.1093/ve/veac121

المؤلفون: Manuela M. Bergmann, Tammy Y.N. Tong, Anna Stubbendorff, Elisabeth H. M. Temme, Claudia Agnoli, Ulrika Ericson, Antonio Agudo, Mélanie Deschasaux, Elisabete Weiderpass, Konstantinos K. Tsilidis, Dagfinn Aune, Guri Skeie, Giovanna Masala, Torkjel M. Sandanger, Emmanuelle Kesse-Guyot, Gianluca Severi, Charlotta Rylander, Francesca Mancini, Miguel A. Rodríguez Barranco, Marie-Christine Boutron-Ruault, Paolo Vineis, Mathilde Touvier, Pietro Ferrari, Marc J. Gunter, Daniel B Ibsen, Jolanda M. A. Boer, María José Pérez, Inge Huybrechts, Matthias B. Schulze, Anika Knuppel, Keren Papier, Elio Riboli, Bernard Srour, Christina C. Dahm, Jessica E. Laine, Tilmann Kühn

المساهمون: Medical Research Council (MRC), Imperial College London, University of Bern, Centre international de Recherche sur le Cancer (CIRC), Bjørknes University College [Oslo, Norvège], Oslo University Hospital [Oslo], University of Potsdam, German Institute of Human Nutrition Potsdam-Rehbruecke [Nuthetal, Germany] (GIHNP-R), National Institute for Public Health and the Environment [Bilthoven] (RIVM), IRCCS Istituto Nazionale dei Tumori [Milano], Lund University [Lund], Aarhus University [Aarhus], Centre de Recherche Épidémiologie et Statistique Sorbonne Paris Cité (CRESS (U1153 / UMR_A_1125 / UMR_S_1153)), Conservatoire National des Arts et Métiers [CNAM] (CNAM)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Conservatoire National des Arts et Métiers [CNAM] (CNAM), Espace régional de réflexion éthique de Normandie (EREN), Escuela Andaluza de Salud Pública [Granada, Spain] (EASP), ibs.GRANADA Instituto de Investigación Biosanitaria [Granada, Spain], Centro de Investigación Biomédica en Red Enfermedades Respiratorias (CIBERES), University of Granada [Granada], University of Oxford [Oxford], Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Università degli Studi di Firenze = University of Florence [Firenze] (UNIFI), German Cancer Research Center - Deutsches Krebsforschungszentrum [Heidelberg] (DKFZ), Istituto per lo Studio, la Prevenzione e la rete Oncologica [Florence, Italy] (ISPRO), Institut d'Investigació Biomèdica de Bellvitge [Barcelone] (IDIBELL), The Arctic University of Norway (UiT), Italian Institute of Technology (IIT), International Arctic Research Center, University of Alaska, Fairbanks, IARC, Kræftens Bekæmpelse, DCS, Deutsches Krebsforschungszentrum, DKFZ, Wellcome Trust, WT: 205212/Z/16/Z, National Research Council, NRC, University of Maryland School of Public Health, SPH, Medical Research Council, MRC: MR/M012190/1, MR/M501669/1, Cancer Research UK, CRUK: C8221/A29017, World Cancer Research Fund, WCRF, Institut National de la Santé et de la Recherche Médicale, Inserm, Bundesministerium für Bildung und Forschung, BMBF, Cancerfonden, Ministerie van Volksgezondheid, Welzijn en Sport, VWS, Ligue Contre le Cancer, Vetenskapsrådet, VR, Instituto de Salud Carlos III, ISCIII, Associazione Italiana per la Ricerca sul Cancro, AIRC, Deutsche Krebshilfe, Institut Gustave-Roussy, Mutuelle Générale de l'Education Nationale, MGEN, NIHR Imperial Biomedical Research Centre, BRC, The coordination of EPIC is financially supported by IARC and also by the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London which has additional infrastructure support provided by the NIHR Imperial Biomedical Research Centre. The national cohorts are supported by: Danish Cancer Society (Denmark), Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle Générale de l'Education Nationale, INSERM (France), German Cancer Aid, German Cancer Research Center, German Institute of Human Nutrition Potsdam-Rehbruecke, Federal Ministry of Education and Research (Germany), Associazione Italiana per la Ricerca sul Cancro-AIRC-Italy, Compagnia di SanPaolo and National Research Council (Italy), Dutch Ministry of Public Health, Welfare and Sports, Netherlands Cancer Registry, LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund, Statistics Netherlands (The Netherlands), Health Research Fund - Instituto de Salud Carlos III, Regional Governments of Andalucía, Asturias, Basque Country, Murcia and Navarra, and the Catalan Institute of Oncology - ICO (Spain), Swedish Cancer Society, Swedish Research Council and County Councils of Skåne and Västerbotten (Sweden), Cancer Research UK (14136 to EPIC-Norfolk, C8221/A29017 to EPIC-Oxford), Medical Research Council (MRC, 1000143 to EPIC-Norfolk, MR/M012190/1 to EPIC-Oxford, UK). JEL was supported by an MRC Early Career Fellowship (MR/M501669/1). We acknowledge the Netherlands Cancer Registry and Statistics Netherlands (The Netherlands) for contributions to data acquisition. KP and AK are supported by the Wellcome Trust (Livestock, Environment and People, LEAP, grant number 205212/Z/16/Z). We acknowledge Corinne Casagrande and Genevieve Nicolas who assisted in the matching of the dietary intake data with the Greenhouse Gas and Landuse data. We also acknowledge Bertrand Hemon for database compilation and Carine Biessy for her contribution to the sensitivity analyses. Where authors are identified as personnel of the IARC or WHO, the authors alone are responsible for the views expressed in this Article and they do not necessarily represent the decisions, policy, or views of the IARC or WHO., Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle G?n?rale de l'Education Nationale, INSERM (France), Health Research Fund - Instituto de Salud Carlos III, Regional Governments of Andaluc?a, Asturias, Basque Country, Murcia and Navarra, and the Catalan Institute of Oncology - ICO (Spain), Swedish Cancer Society, Swedish Research Council and County Councils of Sk?ne and V?sterbotten (Sweden), University of Potsdam = Universität Potsdam, Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke (DifE), Leibniz Association, HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM), Universidad de Granada = University of Granada (UGR), Nuffield Department of Population Health [Oxford], University of Oxford, Université de Versailles Saint-Quentin-en-Yvelines - UFR Sciences de la santé Simone Veil (UVSQ Santé), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Università degli Studi di Firenze = University of Florence (UniFI), Institut Gustave Roussy (IGR), The Arctic University of Norway [Tromsø, Norway] (UiT), European Commission (DG-SANCO), the International Agency for Research on Cancer (IARC), MRC Early Career Fellowship (MR/M501669/1), HAL UVSQ, Équipe

المصدر: e796
e786
Laine, J E, Huybrechts, I, Gunter, M J, Ferrari, P, Weiderpass, E, Tsilidis, K, Aune, D, Schulze, M B, Bergmann, M, Temme, E H M, Boer, J M A, Agnoli, C, Ericson, U, Stubbendorff, A, Ibsen, D B, Dahm, C C, Deschasaux, M, Touvier, M, Kesse-Guyot, E, Sánchez Pérez, M-J, Rodríguez Barranco, M, Tong, T Y N, Papier, K, Knuppel, A, Boutron-Ruault, M-C, Mancini, F, Severi, G, Srour, B, Kühn, T, Masala, G, Agudo, A, Skeie, G, Rylander, C, Sandanger, T M, Riboli, E & Vineis, P 2021, ' Co-benefits from sustainable dietary shifts for population and environmental health : an assessment from a large European cohort study ', The Lancet Planetary Health, vol. 5, no. 11, pp. e786-e796 . https://doi.org/10.1016/S2542-5196(21)00250-3
Digibug. Repositorio Institucional de la Universidad de Granada
instname
Lancet Planetary Health
Lancet Planetary Health, Elsevier, 2021, 5 (11), pp.e786-e796. ⟨10.1016/S2542-5196(21)00250-3⟩
Laine, Jessica E; Huybrechts, Inge; Gunter, Marc J; Ferrari, Pietro; Weiderpass, Elisabete; Tsilidis, Kostas; Aune, Dagfinn; Schulze, Matthias B; Bergmann, Manuela; Temme, Elisabeth H M; Boer, Jolanda M A; Agnoli, Claudia; Ericson, Ulrika; Stubbendorff, Anna; Ibsen, Daniel B; Dahm, Christina Catherine; Deschasaux, Mélanie; Touvier, Mathilde; Kesse-Guyot, Emmanuelle; Sánchez Pérez, Maria-Jose; ... (2021). Co-benefits from sustainable dietary shifts for population and environmental health: an assessment from a large European cohort study. Lancet planetary health, 5(11), e786-e796. Elsevier 10.1016/S2542-5196(21)00250-3 <http://dx.doi.org/10.1016/S2542-5196(21)00250-3>
Dipòsit Digital de la UB
Universidad de Barcelona
Lancet Planetary Health, 2021, 5 (11), pp.e786-e796. ⟨10.1016/S2542-5196(21)00250-3⟩

مصطلحات موضوعية: Health (social science), 030309 nutrition & dietetics, [SDV]Life Sciences [q-bio], Population, Medicine (miscellaneous), 610 Medicine & health, Population health, Cohort Studies, Greenhouse Gases, 03 medical and health sciences, Clinical trials, 0302 clinical medicine, 360 Social problems & social services, Environmental health, 11. Sustainability, Canvi climàtic, Humans, Medicine, VDP::Medisinske Fag: 700, Prospective Studies, 030212 general & internal medicine, education, 2. Zero hunger, Public health, 0303 health sciences, education.field_of_study, Land use, business.industry, Health Policy, Hazard ratio, Public Health, Environmental and Occupational Health, Salut pública, Climatic change, Diet, 3. Good health, European Prospective Investigation into Cancer and Nutrition, [SDV] Life Sciences [q-bio], VDP::Medical disciplines: 700, Quartile, 13. Climate action, Greenhouse gas, Attributable risk, Dieta, business, Environmental Health, Assaigs clínics

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec94eb6aa5807be3aa1f53cc89a69d62
https://doi.org/10.1016/s2542-5196(21)00250-3

المؤلفون: Hassoun, Dorian, Malard, Olivier, Barbarot, Sébastien, Magnan, Antoine O., Colas, Luc

المساهمون: Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Fondation pour la Recherche Médicale, FRM: FDM201906008829, Centre Hospitalier Universitaire de Nantes, CHU de Nantes, This project was supported by Sanofi-Aventis France. This work was also supported by ??l'institut de Recherche en Sant? Respiratoire des Pays de la Loire? (IRSRPL) and by ??l?Appel d?Offre Interne? of CHU de Nantes through the ICART project. DH wants to thank the Fondation pour la Recherche M?dicale, which funded his PhD (FDM201906008829). Luc Colas thanks GlaxoSmithKline who funded his PhD., This project was supported by Sanofi‐Aventis France. This work was also supported by « l'institut de Recherche en Santé Respiratoire des Pays de la Loire» (IRSRPL) and by « l’Appel d’Offre Interne» of CHU de Nantes through the ICART project., DH wants to thank the Fondation pour la Recherche Médicale, which funded his PhD (FDM201906008829). Luc Colas thanks GlaxoSmithKline who funded his PhD., Institut du thorax, Université de Nantes (UN)-IFR26-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre hospitalier universitaire de Nantes (CHU Nantes), Physiopathologie des Adaptations Nutritionnelles (PhAN), Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Virologie et Immunologie Moléculaires (VIM (UR 0892)), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Saclay-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Université de Versailles Saint-Quentin-en-Yvelines - UFR Sciences de la santé Simone Veil (UVSQ Santé), HAL UVSQ, Équipe

المصدر: Clinical and Experimental Allergy
Clinical and Experimental Allergy, Wiley, 2021, 51 (12), pp.1538-1552. ⟨10.1111/cea.14029⟩
Clinical and Experimental Allergy, 2021, 51 (12), pp.1538-1552. ⟨10.1111/cea.14029⟩

مصطلحات موضوعية: [SDV]Life Sciences [q-bio], Immunology, Eczema, medicine.disease_cause, Dermatitis, Atopic, Unmet needs, 03 medical and health sciences, 0302 clinical medicine, Multidisciplinary approach, Humans, Immunology and Allergy, Medicine, Type 2 immunity, 030304 developmental biology, Asthma, 0303 health sciences, Innate immune system, business.industry, Atopic dermatitis, Immune dysregulation, medicine.disease, Phenotype, Immunity, Innate, 3. Good health, [SDV] Life Sciences [q-bio], 030228 respiratory system, Cytokines, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::623c0226544842336035623447e1c9ce
https://doi.org/10.1111/cea.14029

المؤلفون: Jennifer Cable, Anthony Fauci, William E. Dowling, Stephan Günther, Dennis A. Bente, Pragya Dhruv Yadav, Lawrence C. Madoff, Lin‐Fa Wang, Rahul K. Arora, Maria Van Kerkhove, May C. Chu, Thomas Jaenisch, Jonathan H. Epstein, Simon David William Frost, Daniel G. Bausch, Lisa E. Hensley, Éric Bergeron, Ioannis Sitaras, Michael D. Gunn, Thomas W. Geisbert, César Muñoz‐Fontela, Florian Krammer, Emmie de Wit, Pontus Nordenfelt, Erica Ollmann Saphire, Sarah C. Gilbert, Kizzmekia S. Corbett, Luis M. Branco, Sylvain Baize, Neeltje van Doremalen, Marco A. Krieger, Sue Ann Costa Clemens, Renske Hesselink, Dan Hartman

المساهمون: National Institute of Allergy and Infectious Diseases [Bethesda] (NIAID-NIH), National Institutes of Health [Bethesda] (NIH), Coalition for Epidemic Preparedness Innovations [Oslo] (CEPI), Bernhard Nocht Institute for Tropical Medicine - Bernhard-Nocht-Institut für Tropenmedizin [Hamburg, Germany] (BNITM), University of Texas Medical Branch at Galveston, California Institute of Technology (CALTECH), National Institute of Virology - National Influenza Center [Pune, India] (NIV), University of Massachusetts System (UMASS), Duke-NUS Medical School [Singapore], University of Calgary, University of Oxford, Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), University of Colorado Anschutz [Aurora], EcoHealth Alliance [New York], Microsoft Research [Redmond], Microsoft Corporation [Redmond, Wash.], Foundation for Innovative New Diagnostics (FIND), PREVAIL, Centers for Disease Control and Prevention [Atlanta] (CDC), Centers for Disease Control and Prevention, Johns Hopkins Bloomberg School of Public Health [Baltimore], Johns Hopkins University (JHU), Duke University [Durham], University of Manitoba [Winnipeg], Icahn School of Medicine at Mount Sinai [New York] (MSSM), Lund University [Lund], La Jolla Institute for Immunology [La Jolla, CA, États-Unis], Harvard T.H. Chan School of Public Health, Zalgen Labs, Biologie des Infections Virales Émergentes - Biology of Emerging Viral Infections (UBIVE), Centre International de Recherche en Infectiologie (CIRI), École normale supérieure de Lyon (ENS de Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-École normale supérieure de Lyon (ENS de Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut Pasteur [Paris] (IP), Fiocruz Paraná - Instituto Carlos Chagas / Carlos Chagas Institute [Curitiba, Brésil] (ICC), Fundação Oswaldo Cruz / Oswaldo Cruz Foundation (FIOCRUZ), Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Università degli Studi di Siena = University of Siena (UNISI), Bill & Melinda Gates Foundation [Seattle], R.K.A. and M.V.K. presented work funded by the WHO Solidarity Response Fund and the German Federal Ministry of Health COVID-19 Research and Development. R.K.A. would also like to thank the following additional funders of SeroTracker's SARS-CoV-2 evidence synthesis efforts: the Public Health Agency of Canada through Canada's COVID-19 Immunity Task Force, the Robert Koch Institute, and the Canadian Medical Association Joule Innovation Fund. M.V.K. is employed by the WHO, the authors alone are responsible for the views expressed in this publication and they do not necessarily represent the decisions, policies, or views of WHO. E.d.W. and N.v.D. are supported by the Intramural Research Program of NIAID, NIH.

المصدر: Annals of the New York Academy of Sciences
Annals of the New York Academy of Sciences, 2022, 1518 (1), pp.209-225. ⟨10.1111/nyas.14898⟩

مصطلحات موضوعية: Ebola virus, History and Philosophy of Science, General Neuroscience, [SDV]Life Sciences [q-bio], COVID-19, Nipah virus, vaccines, zoonotic diseases, infectious diseases, Lassa virus, General Biochemistry, Genetics and Molecular Biology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a23c08a3f5d9d5840117f6099c6846e
https://pubmed.ncbi.nlm.nih.gov/36183296

المؤلفون: Glentis, Alexandros, Blanch-Mercader, Carles, Balasubramaniam, Lakshmi, Saw, Thuan Beng, d’Alessandro, Joseph, Janel, Sebastien, Douanier, Audrey, Delaval, Benedicte, Lafont, Frank, Lim, Chwee Teck, Delacour, Delphine, Prost, Jacques, Xi, Wang, Ladoux, Benoit

المساهمون: Institut Jacques Monod (IJM (UMR_7592)), Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Laboratoire Physico-Chimie Curie [Institut Curie] (PCC), Institut Curie [Paris]-Institut de Chimie du CNRS (INC)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Mechanobiology Institute [Singapore] (MBI), National University of Singapore (NUS), CHU Lille, Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 (CIIL), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Centre National de la Recherche Scientifique (CNRS), Centre de recherche en Biologie cellulaire de Montpellier (CRBM), Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), Laboratoire Physico-Chimie Curie [Institut Curie] [PCC], Mechanobiology Institute [Singapore] [MBI], Institut Jacques Monod [IJM (UMR_7592)], Centre de recherche en Biologie cellulaire de Montpellier [CRBM], Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 [CIIL], Cellular Microbiology and Physics of Infection Group [Lille] (CMPI), Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Centre National de la Recherche Scientifique (CNRS)-Institut Pasteur de Lille, This work was supported by the LABEX 'Who Am I?' (ANR-11-LABX-0071) (to B.L.), the European Research Council (ERC) (grant no. Adv-101019835) (to B.L.), the Marie Skłodowska-Curie Actions, Individual Fellowship, project 846449 (to W.X.), People Programme (Marie Curie Actions) of the European Union’s Seventh Framework Programme (FP7/2007–2013) under REA grant agreement no. PCOFUND-GA-2013-609102, through the PRESTIGE program coordinated by Campus France (to W.X.), funding from the Labex Who Am I? (ANR-11-LABX-0071) and the 'Initiatives d’excellence' (Idex ANR-11-IDEX-0005-02) transverse project BioMechanOE (TP5) (to W.X.), the Agence Nationale de la Recherche (ANR) 'POLCAM' ANR-17-CE13-0013 funded Glentis et al., Sci. Adv. 8, eabn5406 (2022) 14 September 2022 by the French government (to B.L.), the SystemsX EpiPhysX consortium funding (to C.B.-M.), the NR PRC LUCELL grant (ANR-19-CE13-0014-01) (to B.D.), the ANR-10-EQPX-04-01 (to F.L.), the European Regional Development Fund (FEDER-12001407) (to F.L.), the Groupama Foundation—Research Prize for Rare Diseases 2017 (to D.D. and W.X.), the ANR 'LUCELL' ANR-19-CE13-0014 funded by the French government (to B.D. and D.D.), the Fondation pour la Recherche Médicale (FRM) (to D.D.), the Université de Paris IDEX, ANR-18-IDEX-0001, funded by the French government through its 'Investments for the Future' program (to D.D.), the Human Frontier Science Program, RGP0038/2018 (to D.D., C.T.L., T.B.S., J.P., and W.X.), Lee Kuan Yew Postdoctoral fellowship and Tier 1 grant (R-397-000-320-114) from the Ministry of Education (MOE), Singapore (to T.B.S.), and the National Research Foundation, Singapore, under the Mechanobiology Institute at the National University of Singapore (to C.T.L.)., ANR-11-LABX-0071,WHO AM I,Determinants de l'Identité : de la molécule à l'individu(2011), Delacour, Delphine, Determinants de l'Identité : de la molécule à l'individu - - WHO AM I2011 - ANR-11-LABX-0071 - LABX - VALID

المصدر: Science Advances
Science Advances, American Association for the Advancement of Science (AAAS), 2022, 8 (37), pp.365. ⟨10.1126/sciadv.abn5406⟩
Science Advances, American Association for the Advancement of Science (AAAS), 2022, 8 (37), ⟨10.1126/sciadv.abn5406⟩
Science Advances, 2022, 16 (8(37)), pp.eabn5406. ⟨10.1126/sciadv.abn5406⟩

مصطلحات موضوعية: [SDV] Life Sciences [q-bio], [PHYS]Physics [physics], Multidisciplinary, [SDV]Life Sciences [q-bio]

وصف الملف: application/octet-stream; application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e71174f998ac4890e7acb203e495320
https://doi.org/10.1126/sciadv.abn5406

المؤلفون: Mélissa Mairet-Khedim, Camille Roesch, Nimol Khim, Sreynet Srun, Anthony Bouillon, Saorin Kim, Sopheakvatey Ke, Chhayleang Kauy, Nimol Kloeung, Rotha Eam, Chanra Khean, Chanvong Kul, Sophy Chy, Rithea Leang, Pascal Ringwald, Jean-Christophe Barale, Benoit Witkowski

المساهمون: Microbiologie structurale - Structural Microbiology (Microb. Struc. (UMR_3528 / U-Pasteur_5)), Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Malaria Translational Research Unit (MTRU), Institut Pasteur du Cambodge, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut Pasteur [Paris] (IP)-Université Paris Cité (UPCité), Malaria Molecular Epidemiology (MMEU), Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), National Center for Malariology, Ministry of Health [Phnom Penh], Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), This study was funded by the Bill & Melinda Gates Foundation and Global Fund/UNOPS through WHO and by the Institut Pasteur Department of International Affairs. M.M.K. was supported by the 5% initiative (MIVS-ACT, grant #15SANIN211).

المصدر: Journal of Antimicrobial Chemotherapy
Journal of Antimicrobial Chemotherapy, 2023, 78 (2), pp.411-417. ⟨10.1093/jac/dkac403⟩

مصطلحات موضوعية: Pharmacology, Microbiology (medical), Infectious Diseases, [SDV]Life Sciences [q-bio], Pharmacology (medical)

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49b2456eff46e9ada7671a825c238aa9
https://pubmed.ncbi.nlm.nih.gov/36508338

المؤلفون: Desnos-Ollivier, Marie, Bretagne, Stéphane, Lortholary, Olivier, Dromer, Françoise, French Mycoses Study Group, The

المساهمون: Mycologie moléculaire - Molecular Mycology, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Centre National de Référence Mycoses Invasives et Antifongiques - National Reference Center Invasive Mycoses & Antifungals (CNRMA), Institut Pasteur [Paris] (IP)-Université Paris Cité (UPCité), Laboratoire de Parasitologie-Mycologie [CHU Saint Louis, Paris], Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre d'infectiologie Necker-Pasteur [CHU Necker], Institut Pasteur [Paris] (IP)-CHU Necker - Enfants Malades [AP-HP], Imagine - Institut des maladies génétiques (IHU) (Imagine - U1163), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), This work was supported by Santé Publique France and Institut Pasteur., Members of the French Mycoses Study Group who contributed to the data are, in alphabetical order of the cities, all the French microbiologists and mycologists who sent isolates for characterization of unusual antifungal susceptibility profiles or to contribute to the ongoing surveillance program on the epidemiology of invasive fungal infections in France (YEASTS and RESSIF programs): N. Brieu (CH Aix), T. Chouaki, C. Damiani, A. Totet (CHU Amiens), J. P. Bouchara, D. Chabasse, M. Pihet (CHU Angers), S. Bland (CH Annecy), V. Blanc (CH Antibes), S. Branger (CH Avignon), A. P. Bellanger, L. Millon (CHU Besançon), C. Plassart (CH Beauvais), I. Poilane (Hôpital Jean Verdier, Bondy), I. Accoceberry, L. Delhaes, B. Couprie, F. Gabriel (CH Bordeaux), J. Dunand, A. L. Roux, V. Sivadon-Tardy (Hôpital Ambroise Paré, Boulogne Billancourt), F. Laurent (CH, Bourg en Bresse), S. Legal, E. Moalic, G. Nevez, D. Quinio (CHU Brest), M. Cariou (CH Bretagne Sud), J. Bonhomme, C. Duhamel (CHU, Caen), B. Podac (CH, Chalon sur Saône), S. Lechatch (CH, Charleville-Mézières), C. Soler (Hopital d’Instruction des armées, Clamart), M. Cambon, C. Nourrisson, P. Poirier, D. Pons (CHU, Clermont Ferrand), O. Augereau, I. Grawey (CH, Colmar), N. Fauchet (CHIC, Créteil), A. Bonnin, F. Dalle (CHU, Dijon), P. Cahen, P. Honderlick (CMC, Foch), N. Desbois, C. Miossec (CHU, Fort de France), J. L. Hermann (Hôpital Raymond Poincaré, Garches), M. Cornet, R. Grillot, B. Lebeau, D. Maubon, H. Pelloux (CHU, Grenoble), M. Nicolas (CHU, Guadeloupe), C. Aznar, D. Blanchet, J. F. Carod, M. Demar, (CHU, Guyane), A. Angoulvant (Hôpital Bicêtre, le Kremlin Bicêtre), C. Ciupek (CH, Le Mans), A. Gigandon (Hôpital Marie Lannelongue, Le Plessis Robinson), B. Bouteille (CH Limoges), E. Frealle, D. Poulain, B. Sendid (CHU Lille), D. Dupont, J. Menotti, F. Persat, M.-A. Piens, M. Wallon (CHU, Lyon), C. Cassagne, S. Ranque (CHU, Marseille), T. Benoit-Cattin, L. Collet (CH Mayotte), A. Fiacre (CH Meaux), N. Bourgeois, L. Lachaud, P. Rispail, Y. Sterkers (CHU, Montpellier), M. Machouart (CHU, Nancy), F. Gay-Andrieu, P. Lepape, F. Morio (CHU, Nantes), O. Moquet (CH, Nevers), S. Lefrançois (Hôpital Américain, Neuilly), M. Sasso (CHU, Nimes), F. Reibel (GH, Nord-Essone), M. Gari-Toussaint, L. Hasseine (CHU Nice), L. Bret, D. Poisson (CHR Orléans), S. Brun (Hôpital Avicenne, Paris), C. Bonnal, C. Chochillon, S. Houzé (Hôpital Bichat, Paris), A. Paugam (Hôpital Cochin, Paris), N. Ait-Ammar, F. Botterel, R. Chouk (CHU Henri Mondor, Paris), M. E. Bougnoux, E. Sitterle (Hôpital Necker, Paris), A. Fekkar, R. Piarroux (Hôpital Pitié Salpêtrière, Paris), J. Guitard, C. Hennequin, J.-L. Poirot (Hôpital St Antoine, Paris), M. Gits-Muselli, S. Hamane, C. Lacroix (Hôpital Saint Louis, Paris), S. Bonacorsi, P. Mariani (Hôpital Robert Debré, Paris), D. Moissenet (Hôpital Trousseau, Paris), C. Kauffmann-Lacroix, A. Minoza, E. Perraud, M. H. Rodier (CHU Poitiers), G. Colonna (CH, Porto Vecchio), A. Huguenin, D. Toubas (CHU Reims), S. Chevrier, J. P. Gangneux, F. Robert-Gangneux, C. Guigen (CHU Rennes), O. Belmonte, G. Hoarau, M. C. Jaffar Bandjee, J. Jaubert, S. Picot, N. Traversier (CHU Réunion), L. Favennec, G. Gargala (CHU, Rouen), N. Godineau, C. Tournus (CH, St Denis), C. Mahinc, H. Raberin (CHU, St Etienne), V. Letscher Bru (CHU, Strasbourg), S. Cassaing (CHU, Toulouse), P. Patoz (CH Tourcoing), E. Bailly, J. Chandenier, G. Desoubeaux (CHU Tours), F. Moreau (CH Troyes), P. Munier (CH Valence), E. Mazars (CH Valenciennes), O. Eloy (CH Versailles), E. Chachaty (Institut Gustave Roussy, Villejuif), and members of the NRCMA (Institut Pasteur, Paris): A. Bertho, C. Blanc, A. Boullié, C. Gautier, V. Geolier, D. Hoinard, and D. Raoux-Barbot for technical help, and K. Boukris-Sitbon, F. Lanternier, A. Alanio, and D. Garcia-Hermoso for their expertise and contribution to the surveillance programs.

المصدر: Antimicrob Agents Chemother
Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, 2022, 66 (5), ⟨10.1128/aac.01725-21⟩

مصطلحات موضوعية: Pharmacology, Antifungal Agents, [SDV]Life Sciences [q-bio], yeasts, Microbial Sensitivity Tests, antifungal resistance, Anidulafungin, bacterial infections and mycoses, rare yeast, common yeast, Echinocandins, Lipopeptides, Infectious Diseases, Susceptibility, Caspofungin, Drug Resistance, Fungal, Mutation, Micafungin, polycyclic compounds, FKS mutation, Humans, Candidiasis, Invasive, Pharmacology (medical), MIC distribution

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9519cc295a57acef6fb935f196723b29
https://doi.org/10.1128/aac.01725-21

المؤلفون: Sylvain Levallois, Olivier Disson, Claire Maudet, Marc Lecuit

المساهمون: Biologie des Infections - Biology of Infection, Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Paris (UP), Centre National de Référence Listeria - National Reference Center Listeria (CNRL), Centre collaborateur de l'OMS Listeria / WHO Collaborating Centre Listeria (CC-OMS / WHO-CC), Institut Pasteur [Paris]-Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Service des Maladies infectieuses et tropicales [CHU Necker], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Imagine - Institut des maladies génétiques (IHU) (Imagine - U1163), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP), Research in the Biology of Infection Unit is supported financially by Institut Pasteur, Inserm, ANR and ERC, Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Paris Cité (UPCité), Institut Pasteur [Paris] (IP)-Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)

المصدر: Current Opinion in Microbiology
Current Opinion in Microbiology, Elsevier, 2021, 59, pp.95-101. ⟨10.1016/j.mib.2020.11.006⟩
Current Opinion in Microbiology, 2021, 59, pp.95-101. ⟨10.1016/j.mib.2020.11.006⟩

مصطلحات موضوعية: Microbiology (medical), [SDV]Life Sciences [q-bio], Placenta, Biology, medicine.disease_cause, Microbiology, 03 medical and health sciences, Listeria monocytogenes, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Pregnancy, In vivo, medicine, Humans, Listeriosis, Pathogen, 030304 developmental biology, 0303 health sciences, Innate immune system, 030306 microbiology, medicine.disease, biology.organism_classification, [SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology, Immunity, Innate, 3. Good health, [SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology, Infectious Diseases, Blood-Brain Barrier, Bacteremia, Host-Pathogen Interactions, Immunology, Listeria, Female, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::666402aaf93088cc0c5ed2804345cbed
https://doi.org/10.1016/j.mib.2020.11.006

المؤلفون: Harimalala Ranaivo, Florence Thirion, Christel Béra-Maillet, Susie Guilly, Chantal Simon, Monique Sothier, Laurie Van Den Berghe, Nathalie Feugier-Favier, Stéphanie Lambert-Porcheron, Isabelle Dussous, Loïc Roger, Hugo Roume, Nathalie Galleron, Nicolas Pons, Emmanuelle Le Chatelier, Stanislav Dusko Ehrlich, Martine Laville, Joël Doré, Julie-Anne Nazare

المساهمون: CarMeN, laboratoire, Démonstrateurs - MetaGenoPolis - - MGP2011 - ANR-11-DPBS-0001 - DPBS - VALID, Intensity mapping of the atomic carbon CII line - CONCERTO - - Intensity mapping of the atomic carbon CII line: the promise of a new observational probe of dusty star-formation in post-reionization and reionization epoch2017-01-01 - 0000-00-00 - PE9, ERC-2017-ADG - VALID, Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), French-Clinical Research Infrastructure Network / F-CRIN [Lyon] (Cardiovascular & Renal Clinical Trialists - INI-CRCT ), Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL)-Centre de Recherche en Nutrition Humaine Rhône-Alpes (CRNH-RA), Université de Lyon-Université de Lyon-CHU Grenoble-Hospices Civils de Lyon (HCL)-CHU Saint-Etienne-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)-Université Grenoble Alpes (UGA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-CHU Grenoble-CHU Saint-Etienne-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)-Université Grenoble Alpes (UGA), MetaGenoPolis (MGP (US 1367)), Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), MICrobiologie de l'ALImentation au Service de la Santé (MICALIS), AgroParisTech-Université Paris-Saclay-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Bridor - Groupe LE DUFF [Rennes] (BGLD), This study was funded by Bridor and in part by Metagenopolis grant Agence Nationale de la Recherche ANR-11-DPBS-0001. JD acknowledges funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (Grant agreement ERC-2017-AdG No. 788191 - Homo.symbiosus). We thank all the subjects who participated in this study. We thank Bernard Henrissat who annotated the IGC2 with CAZy., ANR-11-DPBS-0001,MGP,MetaGenoPolis(2011), European Project: PE9, ERC-2017-ADG, Intensity mapping of the atomic carbon CII line: the promise of a new observational probe of dusty star-formation in post-reionization and reionization epoch,Advanced Grant (AdG), PE9, ERC-2017-ADG,CONCERTO(2017), FCRIN/FORCE Network, Centre d'Edition Numérique Scientifique (CENS), École normale supérieure de Lyon (ENS de Lyon)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne] (CHU ST-E)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-CHU Grenoble-Hospices Civils de Lyon (HCL)-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)-Université Grenoble Alpes (UGA)-Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne] (CHU ST-E)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-CHU Grenoble-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)-Université Grenoble Alpes (UGA)

المصدر: Gut microbes
Gut microbes, 2022, 14 (1), pp. 2044722. ⟨10.1080/19490976.2022.2044722⟩
Gut microbes, 2022, 14 (1), pp.2044722. ⟨10.1080/19490976.2022.2044722⟩

مصطلحات موضوعية: Microbiology (medical), Dietary Fiber, gut microbiota, [SDV]Life Sciences [q-bio], Gastroenterology, Dietary fiber diversity, Bread, Microbiology, Gastrointestinal Microbiome, [SDV] Life Sciences [q-bio], Infectious Diseases, Eisenbergiella sp, Cardiovascular Diseases, Parabacteroides distasonis, Metabolome, glycoside hydrolases, Humans, cardiometabolic profile

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3b66717e2ab931b41b5c59f9d8c8b97
https://pubmed.ncbi.nlm.nih.gov/35311446